Active	Status	Sponsor type	Region	Phase	Filter
8 Active 20 Inactive 28 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lupkynis (voclosporin) / Aurinia Pharma
NCT06406205: A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis	Recruiting	3	270	RoW	Voclosporin（QL1074）, Placebo	Qilu Pharmaceutical Co., Ltd.	Lupus Nephritis	06/27	06/28
VOCAL, NCT05288855 / 2020-005807-37: Voclosporin in Adolescent and Pediatric Subjects With Lupus Nephritis	Recruiting	3	40	Japan, US, RoW	Voclosporin, Placebo Oral Capsule	Aurinia Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc.	Adolescent Lupus Nephritis, Pediatric Lupus Nephritis	12/27	06/28
VOCAL-EXT, NCT05962788: Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis	Enrolling by invitation	3	40	Japan, US, RoW	voclosporin	Aurinia Pharmaceuticals Inc., Labcorp Corporation of America Holdings, Inc	Adolescent Lupus Nephritis, Pediatric Lupus Nephritis	12/28	06/29
VOCOVID, NCT04701528: Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients	Completed	2	20	Europe	Voclosporin, Specimen collection for Nuclear acid testing (NAT) on SARS-CoV-2, Tacrolimus	Leiden University Medical Center, Aurinia Pharmaceuticals Inc.	Covid19, Kidney Transplant Infection	03/22	10/22
2020-001467-82: Investigation of the antiviral effect of Voclosporine on COVID-19 in renal transplant patients	Not yet recruiting	2	30	Europe	Voclosporin or Lupkynis, Capsule, soft	Leiden University Medical Center, Aurinia Pharmaceuticals Inc	SARS-CoV-2 infection in Kidney Transplant Recipients, Coronavirus infection in Kidney Transplant Recipients, Diseases [C] - Virus Diseases [C02]
DIVERT, NCT05306873: Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus	Terminated	2	9	US	Mycophenolate Mofetil, CellCept, MMF, Placebo for Mycophenolate Mofetil, Voclosporin, Lupkynis, Lupkynis(TM), Placebo for Voclosporin	National Institute of Allergy and Infectious Diseases (NIAID)	Systemic Lupus Erythematosus	06/24	07/24
NCT01236287: Special Access for the Use of Voclosporin for Kidney Transplantation	No Longer Available	N/A		US	Voclosporin	Weill Medical College of Cornell University	Immunosuppression, Transplantation, Kidney
NCT05337124: A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US	Completed	N/A	229	US	LUPKYNIS, voclosporin	Aurinia Pharmaceuticals Inc., United BioSource, LLC	Lupus Nephritis	01/25	01/25
AUR200 / Aurinia Pharma
No trials found
voclosporin ophthalmic / Aurinia Pharma
No trials found
AUR300 / Aurinia Pharma
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lupkynis (voclosporin) / Aurinia Pharma
NCT06406205: A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis	Recruiting	3	270	RoW	Voclosporin（QL1074）, Placebo	Qilu Pharmaceutical Co., Ltd.	Lupus Nephritis	06/27	06/28
VOCAL, NCT05288855 / 2020-005807-37: Voclosporin in Adolescent and Pediatric Subjects With Lupus Nephritis	Recruiting	3	40	Japan, US, RoW	Voclosporin, Placebo Oral Capsule	Aurinia Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc.	Adolescent Lupus Nephritis, Pediatric Lupus Nephritis	12/27	06/28
VOCAL-EXT, NCT05962788: Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis	Enrolling by invitation	3	40	Japan, US, RoW	voclosporin	Aurinia Pharmaceuticals Inc., Labcorp Corporation of America Holdings, Inc	Adolescent Lupus Nephritis, Pediatric Lupus Nephritis	12/28	06/29
VOCOVID, NCT04701528: Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients	Completed	2	20	Europe	Voclosporin, Specimen collection for Nuclear acid testing (NAT) on SARS-CoV-2, Tacrolimus	Leiden University Medical Center, Aurinia Pharmaceuticals Inc.	Covid19, Kidney Transplant Infection	03/22	10/22
2020-001467-82: Investigation of the antiviral effect of Voclosporine on COVID-19 in renal transplant patients	Not yet recruiting	2	30	Europe	Voclosporin or Lupkynis, Capsule, soft	Leiden University Medical Center, Aurinia Pharmaceuticals Inc	SARS-CoV-2 infection in Kidney Transplant Recipients, Coronavirus infection in Kidney Transplant Recipients, Diseases [C] - Virus Diseases [C02]
DIVERT, NCT05306873: Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus	Terminated	2	9	US	Mycophenolate Mofetil, CellCept, MMF, Placebo for Mycophenolate Mofetil, Voclosporin, Lupkynis, Lupkynis(TM), Placebo for Voclosporin	National Institute of Allergy and Infectious Diseases (NIAID)	Systemic Lupus Erythematosus	06/24	07/24
NCT01236287: Special Access for the Use of Voclosporin for Kidney Transplantation	No Longer Available	N/A		US	Voclosporin	Weill Medical College of Cornell University	Immunosuppression, Transplantation, Kidney
NCT05337124: A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US	Completed	N/A	229	US	LUPKYNIS, voclosporin	Aurinia Pharmaceuticals Inc., United BioSource, LLC	Lupus Nephritis	01/25	01/25
AUR200 / Aurinia Pharma
No trials found
voclosporin ophthalmic / Aurinia Pharma
No trials found
AUR300 / Aurinia Pharma
No trials found